Norinchukin Bank’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-20,998
Closed -$437K 556
2023
Q2
$437K Buy
20,998
+5,655
+37% +$123K 0.01% 509
2023
Q1
$361K Buy
15,343
+387
+3% +$10.4K 0.01% 514
2022
Q4
$418K Sell
14,956
-2,994
-17% -$76.6K 0.01% 492
2022
Q3
$420K Buy
17,950
+1,741
+11% +$52.6K 0.01% 493
2022
Q2
$547K Sell
16,209
-7,094
-30% -$248K 0.01% 467
2022
Q1
$814K Buy
23,303
+1,575
+7% +$53.9K 0.01% 471
2021
Q4
$662K Sell
21,728
-128
-0.6% -$4.17K 0.01% 477
2021
Q3
$717K Buy
21,856
+909
+4% +$29.1K 0.01% 473
2021
Q2
$634K Buy
+20,947
New +$690K 0.01% 479

Other funds holding OGN

Norinchukin Bank's OGN Position: Q3 2023 in Review

Norinchukin Bank sold out of Organon & Co (OGN) in Q3 2023, closing a stake of 20,998 shares — an estimated $437K sold.

Norinchukin Bank first reported a position in OGN in Q2 2021 and held it in 9 quarters. The position peaked at $814K in Q1 2022. 730 funds tracked by Wall St. Rank hold OGN as of Q3 2023.

  • Norinchukin Bank reported no remaining Organon & Co position as of Q3 2023 after selling out during the quarter.
  • Norinchukin Bank sold 20,998 Organon & Co shares in Q3 2023, an estimated $437K.
  • Norinchukin Bank first reported a position in Organon & Co in Q2 2021 and held it in 9 quarters.
  • Norinchukin Bank's Organon & Co position peaked at $814K in Q1 2022.
  • 730 funds tracked by Wall St. Rank held Organon & Co as of Q3 2023.

Based on Norinchukin Bank's 13F filing for Q3 2023, filed 13 Nov 2023.